跳至主要内容
临床试验/NCT02080104
NCT02080104Unknown不适用

Intramuscular Versus Intravenous Prophylactic Oxytocin for the Third Stage of Labour Following Vaginal Delivery: A Randomised Controlled Trial

Hediye Dagdeviren1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
2
试验地点
1
主要终点
early postpartum hemorrhage

研究概览

简要总结

Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour following vaginal delivery: A randomised controlled trial

详细描述

Prevention of postpartum haemorrhage is essential in the pursuit of improved health care for women. In this study investigators aimed to compare intramuscular oxytocin with intravenous oxytocin for the routine prevention of postpartum haemorrhage in women who deliver vaginally.In some countries, intravenous access can not be provided easily . Intramuscular application is faster , easier and tougher enforcement requires less skill and equipment . For this reason, less educated , which can be applied by those offering health services .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Research volunteers, the undersigned, pregnant women
  • Only with vaginal delivery (episiotomy and perineal tears can)
  • > 34 weeks or more will be
  • Cephalic presentation will be
  • At low risk of postpartum hemorrhage

排除标准

  • Multiple pregnancies
  • The presence of uterine myoma
  • Having postpartum hemorrhage in previous pregnancies
  • Placenta previa, polyhydramnios
  • More than four parity
  • Fetal macrosomia
  • Hb <9mg/dl
  • preeclampsia
  • Uterine anomalies
  • Receiving anticoagulant therapy, suspected coagulopathy
  • > 42 weeks of pregnancy
  • Oxytocin allergy -

研究组 & 干预措施

intravenous 10 ıu oxytocin

Active Comparator

group which 2 ampul prophylactic oxytocin given for third stage of labour intravenously after vaginal delivery

干预措施: intarvenous and intramusculer 10 IU oxytocin (Drug)

intramusculer 10 ıu oxytocin

Experimental

group which oxytocin administered intramusculary after vaginal delivery

干预措施: intarvenous and intramusculer 10 IU oxytocin (Drug)

结局指标

主要结局

early postpartum hemorrhage

时间窗: postpartum 24 hours

Blood loss during the birth and postpartum hemorrhage asset (within 24 hours\> 500 cc blood loss)

次要结局

  • Blood transfusion requirement(postpartum 24 hours)

研究者

发起方
Hediye Dagdeviren
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Hediye Dagdeviren

md

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

研究点 (1)

Loading locations...

相似试验